Sweden's Simris Alg Q1 revenue jumps 167%, losses narrow

Simris AB

13/05/2026 07:09

Overview

Sweden biologics firm's Q1 revenue rose 167% yr/yr

Q1 EBITDA and EBIT losses narrowed yr/yr

Company advancing Hammenhög asset sale with two prospective buyers

Outlook

Simris expects to decide on strategic direction for ADC development during second qtr 2026

Company advancing divestment process for Hammenhög assets, expects sale to strengthen finances

Simris evaluating options to expand ADC-payload programme, both requiring additional funding

Result Drivers

ADC PAYLOAD DEVELOPMENT - Co said it initiated new preclinical studies on its proprietary Microcystin-based ADC payload platform to advance innovation and support lead-candidate selection

Company press release: ID:nMFN1gttgS

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
SEK 424,000
Q1 EBIT
-SEK 5.63 mln
Q1 EBITDA
-SEK 2.18 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)